German packaging specialist Gerresheimer Group has announced the acquisition of Wilden Group AG, the European market leader for plastic pharmaceutical drug-delivery systems.
The new takeover will provide Gerresheimer with two new key sectors - Medical Plastic Systems comprising pharmaceutics, consumer health care, diagnostics and medical technology; and Technical Plastic Systems comprising injection moulded products.
As a result, Gerresheimer will now comprise of four divisions - Tubular Glass, Moulded Glass, Life Science Research and Plastic Systems.
In addition, the purchase is expected to bring in around €240m of additional annual sales, swelling the group's sales volume to approximately €900m.
“This [acquisition] marks a giant step in our strategy to generate sustained growth through the acquisition of technology and market leaders in the field of pharma packaging and systems,” commented Gerresheimer ceo, Dr. Axel Herberg. “Through the takeover of Wilden, we have acquired the market, quality and technology leader in all its product segments, which are characterised by highly dynamic growth.”